Join
Live feed
·
NEWSReleasevia Quantisnow
Vaccitech plc logo

Morgan Stanley Downgrades Vaccitech to Equal-Weight, Lowers Price Target to $3.25

ByQuantisnow·Wall Street's wire, on your screen.
VACC· Vaccitech plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VACC (Vaccitech plc) and more on Quantisnow.

Morgan Stanley Downgrades Vaccitech to Equal-Weight, Lowers Price Target to $3.25 | Quantisnow